Related Experiment Videos
Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes
Summary
Researchers identified specific binding sites for chemotactic N-formylmethionyl peptides on human polymorphonuclear leukocytes using radiolabeled fMet-Leu-[3H]Phe. These sites mediate the cells' response to these potent immune signaling molecules.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Synthetic N-formylmethionyl peptides are known chemotactic attractants for human polymorphonuclear leukocytes (PMNs).
- The structure-activity relationship suggests specific cellular binding sites initiate chemotaxis.
Purpose of the Study:
- To directly identify and characterize binding sites for chemotactic peptides on human PMNs.
- To confirm the role of these binding sites in initiating cellular chemotaxis.
Main Methods:
- Utilized tritiated N-formylmethionyl-leucyl-phenylalanine (fMet-Leu-[3H]Phe), a potent chemotactic peptide, for binding studies.
- Assessed binding kinetics, equilibrium dissociation constant (KD), and receptor number per cell.
- Evaluated the specificity of binding using a series of N-formylmethionyl peptides and a competitive antagonist (FPhe-Met).
Main Results:
- Identified specific, rapid, and reversible binding of fMet-Leu-[3H]Phe to human PMNs.
- Determined an equilibrium dissociation constant (KD) of 12-14 nM and approximately 2000 binding sites per cell.
- Demonstrated that the binding specificity mirrors the chemotactic response specificity, with FPhe-Met acting as a competitive antagonist.
Conclusions:
- Directly identified and characterized specific binding sites for chemotactic N-formylmethionyl peptides on human PMNs.
- These binding sites are likely responsible for initiating the chemotactic response of PMNs to these peptides.
- fMet-Leu-[3H]Phe is a valuable tool for studying chemotactic peptide-ligand interactions in immune cells.